NEULAND LABORATORIES
Back to Income Statement
|
NEULAND LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹364 Cr | ₹260 Cr | ₹300 Cr | ₹164 Cr | ₹64 Cr |
What is the latest Consolidated Net Profit of NEULAND LABORATORIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹364 Cr |
| Mar2025 | ₹260 Cr |
| Mar2024 | ₹300 Cr |
| Mar2023 | ₹164 Cr |
| Mar2022 | ₹64 Cr |
How is Consolidated Net Profit of NEULAND LABORATORIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹364 Cr | 39.94 | |
| Mar2025 | ₹260 Cr | -13.32 | |
| Mar2024 | ₹300 Cr | 83.51 | |
| Mar2023 | ₹164 Cr | 156.21 | |
| Mar2022 | ₹64 Cr | - | |
Compare Consolidated Net Profit of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹29,817.3 Cr | -1.6% | 26.4% | 77.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | 1% | -2.7% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,976.0 Cr | 0.7% | 17.1% | 40.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | -0.3% | -3.7% | 37.9% | Stock Analytics | |
| CIPLA | ₹115,216.0 Cr | -0.3% | 2.3% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | -1.4% | 0.7% | -6.2% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -1.6% |
26.4% |
77.6% |
| SENSEX | -0.6% |
1% |
-3.7% |
You may also like the below Video Courses